RAB27A Knockout HAP1 Cell Line

The choice depends on whether you are studying RAB27A's role in regulated secretion (cytotoxic granules, melanosomes, dense granules) or modeling Griscelli syndrome type 2. The Knockout line is the standard tool for asking whether RAB27A is required for these processes — RAB27A is essential for cytotoxic T lymphocyte and NK cell granule release, melanosome transport, and platelet dense granule secretion. Overexpression is useful for studying RAB27A effector interactions or for testing constitutively active (Q78L) versus dominant negative (T23N) mutants. For regulated secretion research, the EDITGENE RAB27A Knockout in HAP1 is a clean genetic background for mechanistic studies of RAB27A-effector interactions (Slp/Munc13-4/melanophilin/MyRIP). RAB27A mutations cause Griscelli syndrome type 2 (immune dysfunction, partial albinism, neurological symptoms) — disease variant rescue enables genotype-function studies. Note that physiologically relevant RAB27A research in cytotoxic immunity requires immune cell models.

Primary applications: • Effector interaction studies: co-immunoprecipitation analysis of RAB27A-Slp family, RAB27A-Munc13-4, RAB27A-melanophilin, and RAB27A-MyRIP interactions. • Exosome secretion: extracellular vesicle release assays given RAB27A's role in multivesicular body (MVB) docking and exosome secretion. • Griscelli syndrome type 2 modeling: rescue with patient-derived RAB27A mutations for genotype-function correlation studies. • Regulated exocytosis: in heterologous contexts, RAB27A-dependent secretion of model cargoes. EDITGENE recommends this model for researchers investigating regulated secretion, exosome biology, and Griscelli syndrome mechanisms. Physiologically relevant immune secretory function requires cytotoxic immune cell models.

Yes. RAB27A rescue experiments are well-established for regulated secretion research: • Construct design: use a codon-modified RAB27A sequence with a small N-terminal tag (FLAG, HA, GFP). Preserve C-terminal prenylation motif for membrane targeting. • GTPase cycle rescue: Q78L (constitutively active) and T23N (dominant negative) mutants enable cycle-specific studies. • Griscelli syndrome 2 mutation rescue: patient-derived RAB27A mutations enable disease genotype-function correlation. • Effector-binding-deficient rescue: switch region mutations (e.g., specific Slp-binding deficient mutants) enable dissection of effector-specific functions. • Functional readout: rescue should restore RAB27A effector recruitment and secretory phenotypes. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.